Prevalence of Low Serum Complement in Lupus Nephritis Patients in Ratchaburi Hospital

Authors

  • Karn Wongtuntakorn M.D., Ratchaburi Hospital

Keywords:

lupus nephritis, low serum complement, prevalence

Abstract

Objective: This is to determine the prevalence of low serum complement in patients with lupus nephritis and correlation between low serum complement and type of lupus nephritis in Ratchaburi Hospital.

Methods:  A retrospective study based on medical records included patients with lupus nephritis diagnosed by kidney biopsy at Ratchaburi Hospital over a period of 11 years, from 1 January 2011 to 31 December 2021. Demographic data, serum creatinine, urine protein, and serum complement were analyzed by using frequency, percentage, mean, and standard deviation. Correlation between low serum complement and type of lupus nephritis were analyzed by using chi-square statistics.

Results: A total of 128 patients with lupus nephritis had a mean age of 31.6 ± 11.9 years, 83.6% were female. The common type of lupus nephritis was type 4 (54.7%), type 5 (22.6%), and type 3 (18.0%). Among 67 patients with serum complement, the prevalence of low serum C3 in lupus nephritis class 3 was 71.4%, class 4 was 100%, class 5 was 46.2%, and was not found at all in class 6. In addition, the prevalence of low serum C4 in lupus nephritis class 3 was 42.9%, class 4 was 71.8%, class 5 was 23.1%, and was not found at all in class 6. Statistically significant factors associated with proliferative lupus nephritis included younger age, low serum complement C3  which was found in proliferative lupus nephritis 89.1%, and low serum complement C4 was found in proliferative lupus nephritis 91.9%.

Conclusion: This study reported that low serum complement, both C3 and C4, were associated with the severity of inflammation in lupus nephritis. And low serum complement, C3 or C4 statistically significant found in proliferative lupus nephritis, may be chosen as an alternative to renal biopsy in contraindicated cases or there is a rush for treatment.

References

Yap DY, Chan TM. Lupus nephritis in Asia: clinical features and management. Kidney Dis (Basel) 2015;1(2):100–9. doi: 10.1159/000430458.

Cozzani E, Drosera M, Gasparini G, et al. Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis 2014;2014:321359. doi:10.1155/2014/321359

Ayano M, Horiuchi T. Complement as a biomarker for systemic lupus erythematosus. Biomolecules 2023;13(2):367. doi:10.3390/biom13020367

Moroni G, Radice A, Giammarresi G, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009;68(6):234–7. doi:10.1136/ard.2008.094508

Richmond RG. Lupus nephritis: role of serum complement levels as prognostic marker. J Clin Res Rep 2020;5(4):1–5. doi:10.31579/2690-1919/124.

Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64(8):2677–86. doi:10.1002/art.34473

Markowitz GS, D'Agati VD. The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 2007;71(6):491–5. doi:10.1038/sj.ki.5002118

บัญชา สถิระพจน์, นริศรา อภัยจิตต์, อุปถัมภ์ ศุภสินธ์. ลักษณะอาการทางคลินิก และพยาธิวิทยาทางไตในผู้ป่วยโรคไตอักเสบในโรงพยาบาลพระมงกุฎเกล้า. เวชสารแพทย์ทหารบก 2553;63(2):53–64.

ไพบูลย์ อรุณมานะกุล. ผลการรักษาโรคไตอักเสบลูปัสชนิดรุนแรง. วารสารสาธารณสุขล้านนา 2009;5(1):36–44.

Published

2024-06-30

How to Cite

1.
Wongtuntakorn K. Prevalence of Low Serum Complement in Lupus Nephritis Patients in Ratchaburi Hospital. Reg 4-5 Med J [internet]. 2024 Jun. 30 [cited 2026 Feb. 22];43(2):171-8. available from: https://he02.tci-thaijo.org/index.php/reg45/article/view/270042